Latest Articles

Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial.

Prolonged Thromboprophylaxis with LMWH after Abdominal or Pelvic Surgery

Maternity Clot Risk Model to Predict Women at Risk of VTE

Independent Risk Factors for Venous Thromboembolism

Trends in Pulmonary Embolism-related mortality in Europe

An analysis of vital registration data from the WHO Mortality Database (2000-2015).

Specific Patient Characteristics Linked to Below Average Quality of Life in Patients with Recent Venous Thromboembolism (VTE)

Many associated factors are modifiable indicating potential benefit from planned strategies.

Risk for Pulmonary Embolism Continues Beyond 6 Weeks of Surgery

Guidelines recommend postoperative prophylactic anticoagulation for 1-5 weeks.

Global use of RAM and Thromboprophylaxis in hospitalized patients

Evaluation Of Comparative Efficacy and Safety of Thromboprophylaxis Agents Among Critically Ill Patients

This systematic review and network meta-analysis revealed that the use of low-molecular-weight heparin (LMWH) may be more effective than unfractionated heparin (UFH) in reducing incidence of deep vein thrombosis (DVT) among critically ill patients.